Alignment 医疗

最新新闻

• 评级变动
  Goldman Sachs Maintains Alignment Healthcare(ALHC.US) With Buy Rating, Raises Target Price to $25
  \u5e02\u573a\u8d44\u8baf · 2026/5/4
• Piper Sandler Maintains Alignment Healthcare(ALHC.US) With Buy Rating
  \u5e02\u573a\u8d44\u8baf · 2026/10/5
• 评级变动
  BofA Securities Maintains Alignment Healthcare(ALHC.US) With Buy Rating
  \u5e02\u573a\u8d44\u8baf · 2026/8/1
• 评级变动
  Baird Maintains Alignment Healthcare(ALHC.US) With Buy Rating, Raises Target Price to $28
  \u5e02\u573a\u8d44\u8baf · 2026/1/30
• Analysts Conflicted on These Healthcare Names: Alignment Healthcare (ALHC), Tilray (TLRY) and Fractyl Health, Inc. (GUTS)
  TipRanks · 2026/10/5
• 评级变动
  TD Cowen Maintains Alignment Healthcare(ALHC.US) With Buy Rating, Maintains Target Price $25
  \u5e02\u573a\u8d44\u8baf · 2026/5/4
• 评级变动
  J.P. Morgan Initiates Alignment Healthcare(ALHC.US) With Buy Rating, Announces Target Price $26
  \u5e02\u573a\u8d44\u8baf · 2026/2/5
• William Blair Maintains Alignment Healthcare(ALHC.US) With Buy Rating
  \u5e02\u573a\u8d44\u8baf · 2026/9/16
• 评级变动
  TD Cowen Maintains Alignment Healthcare(ALHC.US) With Buy Rating, Raises Target Price to $21
  \u5e02\u573a\u8d44\u8baf · 2026/8/3
• 评级变动
  TD Cowen Maintains Alignment Healthcare(ALHC.US) With Buy Rating, Cuts Target Price to $21
  \u5e02\u573a\u8d44\u8baf · 2026/8/1
• 评级变动
  BofA Securities Maintains Alignment Healthcare(ALHC.US) With Buy Rating, Raises Target Price to $25
  \u5e02\u573a\u8d44\u8baf · 2026/5/1
• 评级变动
  KeyBanc Maintains Alignment Healthcare(ALHC.US) With Buy Rating, Raises Target Price to $28
  \u5e02\u573a\u8d44\u8baf · 2026/1/22
• 评级变动
  Raymond James Maintains Alignment Healthcare(ALHC.US) With Buy Rating, Raises Target Price to $22
  \u5e02\u573a\u8d44\u8baf · 2026/5/8
• 评级变动
  Raymond James Maintains Alignment Healthcare(ALHC.US) With Buy Rating
  \u5e02\u573a\u8d44\u8baf · 2026/7/10
• 评级变动
  Piper Sandler Maintains Alignment Healthcare(ALHC.US) With Buy Rating, Maintains Target Price $30
  \u5e02\u573a\u8d44\u8baf · 2026/3/2
• Form 144 | Alignment Healthcare(ALHC.US) Director Proposes to Sell 6.52 Million in Common Stocks
  \u5e02\u573a\u8d44\u8baf · 2026/9/11
• 评级变动
  Raymond James Initiates Alignment Healthcare(ALHC.US) With Buy Rating, Announces Target Price $19
  \u5e02\u573a\u8d44\u8baf · 2026/8/3
• 评级变动
  KeyBanc Maintains Alignment Healthcare(ALHC.US) With Buy Rating, Maintains Target Price $28
  \u5e02\u573a\u8d44\u8baf · 2026/7/31
• 评级变动
  Goldman Sachs Maintains Alignment Healthcare(ALHC.US) With Buy Rating, Maintains Target Price $25
  \u5e02\u573a\u8d44\u8baf · 2026/8/3
• J.P. Morgan Maintains Alignment Healthcare(ALHC.US) With Buy Rating, Cuts Target Price to $22
  \u5e02\u573a\u8d44\u8baf · 2026/8/4

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。